Cristina-mihaela Lacatusu

Iasi, IS 700111, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients.

Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients.

Journal: Journal of clinical medicine

Published: June 05, 2025

Obesity, type 2 diabetes and cancers of the digestive system.

Obesity, type 2 diabetes and cancers of the digestive system.

Journal: Seminars in cancer biology

Published: March 21, 2025

Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review.

Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review.

Journal: Journal of clinical medicine

Published: March 11, 2025

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis.

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis.

Journal: Journal of clinical medicine

Published: January 06, 2025

Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Nutrients

Published: June 05, 2024

Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up.

Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up.

Journal: Diagnostics (Basel, Switzerland)

Published: July 28, 2023

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives.

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives.

Journal: Metabolites

Published: March 22, 2023

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes.

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes.

Journal: Biomedicines

Published: August 27, 2022

Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients.

Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients.

Journal: Journal of personalized medicine

Published: August 05, 2022

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.

Journal: Life (Basel, Switzerland)

Published: July 18, 2022

Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine.

Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine.

Journal: American journal of therapeutics

Published: June 10, 2022

Self-Reported Satisfaction to Treatment, Quality of Life and General Health of Type 2 Diabetes Patients with Inadequate Glycemic Control from North-Eastern Romania.

Self-Reported Satisfaction to Treatment, Quality of Life and General Health of Type 2 Diabetes Patients with Inadequate Glycemic Control from North-Eastern Romania.

Journal: International journal of environmental research and public health

Published: February 18, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026